Suvretta Capital Management, LLC, Director, 10% Owner at Benitec Biopharma Inc. (BNTC), bought 31,057 shares at $13.22 ($399K) on 2025-03-31, disclosed to the SEC on 2025-04-02.
Open-market purchase of $399k BNTC by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.63 | 1,267 | $16K | 4.0% |
| 2 | $12.63 | 9,503 | $120K | 30.1% |
| 3 | $12.63 | 9,503 | $120K | 30.1% |
| 4 | $13.22 | 670 | $9K | 2.2% |
| 5 | $13.22 | 5,057 | $67K | 16.8% |
| 6 | $13.22 | 5,057 |
| $67K |
| 16.8% |
| Total | $12.83 avg | 31,057 | $399K | 100% |
| Filing → |
| BNTC | BUY | 2024-12-05 | $403K | — | Filing → |